<DOC>
	<DOC>NCT00916864</DOC>
	<brief_summary>The aim of the study is to estimate the diagnostic accuracy of a combined biomarker test (including NMDA-Receptor fragments [NR2-peptide] and Glial fibrillary acidic protein) used to differentiate between cerebral ischemia and intracerebral hemorrhage in patients with acute hemispheric stroke.</brief_summary>
	<brief_title>Biomarker for Rapid Diagnosis of Hemispheric Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<criteria>hemiparesis at least one sign of cortical involvement (e.g., aphasia, neglect, gaze deviation, reduced level of consciousness) hospital admission within 4.5 hours after symptom onset stroke/TIA within the last 3 months traumatic brain injury within the last 3 months history of brain tumor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>